Wedbush Securities’s MediciNova MNOV Stock Holding History

Wedbush Securities’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,500	Closed	-$55K	–	934
2020 Q3	$55K	Buy	+10,500	New	+$60.6K	0.01%	873

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wedbush Securities's MNOV Position: Q4 2020 in Review

Wedbush Securities sold out of MediciNova (MNOV) in Q4 2020, closing a stake of 10,500 shares — an estimated $55K sold.

Wedbush Securities first reported a position in MNOV in Q3 2020 and held it in 1 quarter. The position peaked at $55K in Q3 2020. 57 funds tracked by Wall St. Rank hold MNOV as of Q4 2020.

Wedbush Securities reported no remaining MediciNova position as of Q4 2020 after selling out during the quarter.
Wedbush Securities sold 10,500 MediciNova shares in Q4 2020, an estimated $55K.
Wedbush Securities first reported a position in MediciNova in Q3 2020 and held it in 1 quarter.
Wedbush Securities's MediciNova position peaked at $55K in Q3 2020.
57 funds tracked by Wall St. Rank held MediciNova as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.